In vitro permeation studies of nanoemulsions containing ketoprofen as a model drug

Drug Delivery
Beom Su KimCheo Sang Kim

Abstract

We prepared a nanoemulsion system with benzyl alcohol/ ethanol/Solutol/smash(R) HS 15 /water. Ketoprofen was used as a model drug in this study. The nanoemulsions of this system evidenced a high degree of stability. The droplet diameter did not change over a period of at least 3 months. The nanoemulsion containing 4% benzyl alcohol evidenced a permeation rate higher than was observed with the 1% and 2% nanoemulsions. Also the nanoemulsion containing 1% Solutol(R) HS 15 provided a permeation rate higher than was seen with the 2% and 4% nanoemulsions. All ketoprofen-loaded nanoemulsions enhanced the in vitro permeation rate through mouse skins as compared to the control.

References

Mar 1, 1975·The Journal of Investigative Dermatology·T J Franz
Nov 1, 1990·Journal of Pharmaceutical Sciences·S C Chi, H W Jun
Oct 14, 1988·Journal of Chromatography·J H Satterwhite, F D Boudinot
Feb 1, 1995·Biological & Pharmaceutical Bulletin·I SaitohY Takagishi
Oct 1, 1994·Pharmaceutical Research·J HiltonM F Wilks
Apr 8, 1998·The Journal of Pharmacy and Pharmacology·S A MikulakM E Nimni
Feb 24, 1999·Drug Development and Industrial Pharmacy·Y TakanashiT Nagai
Jun 1, 1999·Drug Development and Industrial Pharmacy·G J RheeC H Lee
Jan 21, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·C ValentaJ Heidlas
Sep 23, 2000·International Journal of Pharmaceutics·M FujiiM Matsumoto
Dec 6, 2000·Advanced Drug Delivery Reviews·M J Lawrence, G D Rees
Sep 29, 2001·International Journal of Pharmaceutics·Y S RheeS C Chi
Mar 8, 2003·International Journal of Pharmaceutics·S PeltolaA Urtti
Feb 26, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Amnon C Sintov, Lillia Shapiro
Aug 18, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Huabing ChenXiangliang Yang
Apr 8, 2006·International Journal of Pharmaceutics·Huabing ChenXiangliang Yang
Aug 1, 2006·International Journal of Pharmaceutics·Yue YuanDa-fang Zhong
Aug 24, 2006·International Journal of Pharmaceutics·X ZhaoY Li

❮ Previous
Next ❯

Citations

Sep 17, 2009·AAPS PharmSciTech·Adnan AzeemSushama Talegaonkar
Apr 2, 2014·TheScientificWorldJournal·Bhupinder KapoorYogyata Vaidya
Sep 15, 2015·Pharmaceutical Development and Technology·Fariba EsmaeiliAmir Amani
Apr 23, 2013·Journal of Drug Targeting·Yan WuHong-Duo Chen
Jun 19, 2012·Expert Opinion on Drug Delivery·Faiyaz ShakeelIbrahim A Alsarra
Aug 16, 2012·Journal of Colloid and Interface Science·Gautam C KiniClarence A Miller
Feb 15, 2011·Advanced Drug Delivery Reviews·Tarl W ProwMichael S Roberts
Mar 1, 2016·Soft Matter·Ankur GuptaPatrick S Doyle
Sep 14, 2013·The Journal of Pharmacy and Pharmacology·Sonja R VučenDragan Uskoković
Jul 14, 2010·Journal of Cosmetic Dermatology·William AbramovitsPeter Arrazola
May 1, 2016·International Journal of Pharmaceutics·Airlla L M CavalcantiBolívar P G L Damasceno
Nov 28, 2019·Current Drug Research Reviews·Khaleel Basha SabjanKaviyarasu Kasinathan
Nov 28, 2017·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Roxana JijieSabine Szunerits
Sep 22, 2017·Pharmaceutics·Christofori M R R NastitiMichael S Roberts
Jul 25, 2019·Recent Patents on Anti-infective Drug Discovery·Kumar AnandSanmoy Karmakar
Sep 25, 2021·Expert Opinion on Drug Delivery·Varalakshmi VelagacherlaUsha Y Nayak
Aug 19, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Sourav ThakurVijay Mishra

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.